ABOUT

When Almac Clinical Technologies came to us in late 2019 to create a standalone identity for its new modular IRT offering, our solution was to work with the company’s marketing team to define a clear platform for expression that could be communicated as an applicable benefit to the biopharmaceutical industry.

Crafting a name that would differentiate the brand from its parent IXRS, ‘Simplify’ purposively removes the complex barriers often associated with interactive response technology and provides the framework for a modular IRT platform solution that is configurable and scalable.

Simplifying the traditionally rigid one-size-fits-all IRT proposition with a dynamic and bespoke solution that empowers the biopharmaceutical industry to quickly build and deploy a platform solution configured to their specific study’s needs, ‘Simplify’ does exactly what it says on the box.

Visually the brandmark was created to communicate the modular benefits of Simplify to the biopharmaceutical industry, reinforcing how modules could be added or removed as needed. Working as both a one colour and full colour solution, the Simplify name and brandmark is like the IRT solution it serves, designed to be adaptable.

Completed during lockdown, Simplify launched digitally in 2020 with the brand rolling out across targeted industry sites including Fierce Biotech and Labiotech with an expansive suite of print and exhibition collateral including brand guidelines supplied to let the Almac Clinical Technologies marketing for future application.